Fundraising FoxThe Vertical Group
Venture capitalBerkeley Heights · Seed–Series A · 4 people tracked
Find your way into The Vertical Group
122 people in our graph can introduce you to the The Vertical Group team.
Sign up to see every warm intro you have to The Vertical Group
- Paths you didn't know you had: your email and LinkedIn already hold routes to the The Vertical Group team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
The Vertical Group invests in medical technology and biotechnology companies, typically at early stages. Its principals bring more than 40 years of experience as founders, early-stage investors, major shareholders, and executives across many successful medical technology companies. The firm emphasizes deep operating and investing expertise in the medical device and life sciences fields, and its principals are active in the National Venture Capital Association, having helped found the Association's Medical Industry Group.
Source: firm website, verified Aug 3, 2026.
Team · 4 people
from the firm's website & public directories
What they invest in
from 17 of 26 portfolio companiesHealthtech ×13Biotech ×5Medical Devices ×5Hardware ×3Digital Health ×2Enterprise Software ×2Media & Entertainment ×2Advanced Manufacturing ×1
HQs:United States×14
Investments · 26 tracked
founders shown can be your intro pathBy year:2024 · 12021 · 22017 · 12015 · 42012 · 12005 · 110 dated
Omada Health provides virtual-first, integrated care programs for chronic disease management, delivered as data-driven solutions for employers, health plans, and healthcare organizations.
Digital HealthHealthtechWellness & FitnessSan Francisco, US
Andrew DiMichelle(Executive Officer, Director)Adrian James(Founder)inSean Duffy(Founder)inWei-Li Shao(President)inSteve Cook(Chief Financial Officer)inAndrew DiMichele(Founder)
Co-investorsaMoonAndreessen HorowitzBlackbird VenturesCanvas VenturesCivilization Ventures Management, LlcDesigner Fund+18 more
.jpeg){kind=logo}
Outset Medical develops dialysis technology aimed at driving broader adoption and lowering the cost of care for patients and healthcare providers.
Enterprise SoftwareHardwareHealthtechMedical DevicesSan Jose, US
Nabeel Ahmed(Executive Officer)inMarc Nash(Executive Officer)inJohn Brottem(General Counsel)inLeslie Trigg(Chair and CEO)inJeff Mack(Executive Officer)inRenee Gaeta(Chief Financial Officer)in
Co-investorsDurable Capital PartnersFidelity InvestmentsT. Rowe PriceWarburg Pincus
Route 92 Medical develops neurointervention catheter systems and devices aimed at improving outcomes for neurovascular patients, including stroke treatment.
BiotechHardwareHealthtechMedical DevicesSan Mateo, US
Dr. Chou(Founder & Chief Executive Officer)Cindy Lynch(Executive Officer)inDr. Joey English(Chief Medical Officer)Tony Chou(Founder)in
BoardJack Lasersohn(Director)inTamir Meiri(Director)
Board seatJack W. Lasersohn· per SEC Form D
Co-investorsNovo HoldingsNorwest Venture PartnersRunway Growth CapitalUS Venture PartnersSectoral Asset ManagementSofinnova Ventures+1 more
HealthtechSunnyvale, US
Erica Rogers(Executive Officer, Director)
BoardJack Lasersohn(Director)inNoah Knauf(Director)Elizabeth Weatherman(Director)Richard Mott(Director)
Board seatJack W. LasersohnTony Chou· per SEC Form D
Co-investorsB Capital GroupNorwest Venture PartnersWarburg Pincus
.jpeg){kind=logo}
CustomDyn provides design, engineering, and fabrication services across multiple materials including steel, aluminum, wood, and plastics.
Advanced ManufacturingHardware
Eater is a digital media brand covering food and dining culture through a national website, iOS app, local city sites, YouTube channel, podcasts, and newsletters.
ConsumerFoodTechMedia & EntertainmentNew York, US
Stephanie Wu(Editor-in-Chief)inJill Dehnert(Publisher)
Co-investorsGotham Gal VenturesAndreessen HorowitzBrooks ReitzQED InvestorsShine CapitalUnion Square Ventures (USV)
Developed biotech research instruments for measuring molecular binding; acquired by Pall Corporation for $159M.
Co-investorsLatterell Venture PartnersMPM BioImpactOrbiMedVersant Ventures
Core-Rx is an independent agency that provides pharmaceutical and healthcare marketing services, including campaign development, creative direction, and digital innovation.
Enterprise SoftwareHealthtechMarketing TechMedia & EntertainmentNew York, US
Shana Robinson(Founder, CEO and President)
Co-investorsRed River West
Monteris develops minimally invasive laser ablation technology (LITT) used to treat brain conditions including oncology tumors and drug-resistant epilepsy.
BiotechHealthtechMedical DevicesPlymouth, US
JAMES ERICKSON(Executive Officer)inMARTIN EMERSON(Executive Officer, Director)John Schellhorn(Executive Officer, Director, Promoter)inRobert K Davidson(Executive Officer)
BoardRICHARD EMMITT(Director)inGregory Barrett(Director)
Co-investorsVensana Capital
Mereo BioPharma is a rare disease drug developer that funds and advances novel therapeutic candidates not progressed by their originating pharmaceutical or biotech companies, with lead programs in osteogenesis imperfecta and Alpha-1 Antitrypsin Deficiency-associated Lung Disease.
BiotechHealthtech
Co-investorsLatterell Venture Partners
ProteinSimple developed instruments and consumables for protein analysis; acquired by Techne/Bio-Techne for $300M in 2014.
Co-investorsLatterell Venture PartnersMitsui Global Investment
Remedy Pharmaceuticals is a pharmaceutical company developing Cirara, an investigational drug studied in clinical trials for patients who have suffered a stroke.
BiotechHealthtechNew York, US
SVEN JACOBSON(Executive Officer, Director)
BoardDAVID GELIEBTER(Director)
Co-investorsBroadview Ventures
Silk Road Medical develops medical devices for treating carotid artery disease, including technology used in the TCAR (transcarotid artery revascularization) procedure.
HealthtechMedical Devices
Co-investorsNorwest Venture PartnersWarburg Pincus
StartUp Health operates a private global membership community for health innovators — including founders, healthcare executives, investors, and clinicians — offering a member network app, live AMAs and fireside chats, in-person event access, and a content library.
Digital HealthHealthtechNew York, US
Steven Krein(Strategic Advisor & Co-founder)inUnity Stoakes(CEO, President & Co-founder)inBari Krein(CSO, Managing Partner)inRob Belsky(CFO)in
BoardWayne Kimmel(Director)Jerry Levin(Director)
Co-investorsKaiser Permanente VenturesTrue Ventures
HealthtechLexington, US
Simon Williams(Executive Officer, Director)John Hartnett(Executive Officer)
BoardRichard B. Emmitt(Director)inEdward M. Giles(Director)Anthony J. Sinskey(Director)
Co-investorsNovartis Venture Fund
Transforming the lives of patients through a functional cure for Type 1 Diabetes
BiotechSan Diego, US
Brittany Bradrick(Executive Officer)Anne Sandan(Executive Officer)Elizabeth Bui(Executive Officer)Steve White(Executive Officer)Howard Foyt(Executive Officer)inKevin D'Amour(Executive Officer)in
Co-investorsArtis VenturesATEL VenturesBain Capital Life SciencesRA CapitalSanderling VenturesJohnson & Johnson Innovation – JJDC+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
El Camino Real Medical, Inc.Highway 1 Medical, Inc.BiosetincInPhenixMeritage PharmaNewcoPetrolix WebsitePrevent
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 5
2 IPOs · 3 acquisitions · showing 4Omada HealthNASDAQ: OMDAOutset MedicalNASDAQ: OMForteBioacq. by PallOncoMed Websiteacq. by Mereo BioPharma
Frequently asked questions
- How many investments has The Vertical Group made?
- The Vertical Group has 26 tracked investments, 5 of which have exited.
- What stage does The Vertical Group invest at?
- The Vertical Group invests at the Seed, Series A stages.
- What is The Vertical Group's typical check size?
- The Vertical Group typically writes checks of $250K – $5M.
- What sectors does The Vertical Group focus on?
- The Vertical Group focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is The Vertical Group located?
- The Vertical Group is headquartered in Berkeley Heights, US.
- Who does The Vertical Group co-invest with?
- The Vertical Group most often shares deals with Latterell Venture Partners, Kaiser Permanente Ventures, Andreessen Horowitz, among 31 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.